Lung cancer cell-derived EDA-containing fibronectin induces an inflammatory response from monocytes and promotes metastatic tumor microenvironment.
Asif AminTaseem A MokhdomiShoiab BukhariZubair WaniNaveed Anjum ChikanBasit A ShahAabid M KoulUmer MajeedFaizah FarooqAyub QadriRaies A QadriPublished in: Journal of cellular biochemistry (2021)
Tumor-associated macrophages (TAMs) play a pivotal role in facilitating tumor growth and metastasis. This tumor-promoting propensity of TAMs sets in as a result of their complex cross-talk with tumor cells mediated primarily by tumor cell-secreted proteins in the tumor microenvironment. To explore such interactions, we employed an immunoscreening approach involving the immunization of Balb-c mice with model human lung carcinoma cell line, A549. From serological examination combined with mass spectrometric analysis, EDA-containing fibronectin (EDAFN ) was identified as a conspicuous immunogenic protein in A549 cell secretome. We showed that A549 secreted EDAFN engages TLR-4 on THP-1 monocytes to drive the proinflammatory response via NF-κB signaling cascade. Conversely, A549 derived EDAFN potentiates their metastatic capacity by inducing epithelial-mesenchymal transition through its autocrine activity. In conclusion, the study proposes a possible mechanism of cellular cross-talk between lung cancer cells and associated monocytes mediated by lung cancer-derived EDAFN and resulting in the establishment of proinflammatory and metastatic tumor microenvironment.
Keyphrases
- inflammatory response
- epithelial mesenchymal transition
- squamous cell carcinoma
- small cell lung cancer
- single cell
- dendritic cells
- lps induced
- signaling pathway
- cell therapy
- toll like receptor
- immune response
- lipopolysaccharide induced
- metabolic syndrome
- pi k akt
- nuclear factor
- adipose tissue
- amino acid
- cell proliferation